Intracranial aneurysm, also known as brain or cerebral aneurysm, is a bulging, weakened area in the wall of an artery in the brain. It results in an abnormal ballooning, widening, or bleb. An intracranial aneurysm majorly occurs in an artery located in the front part of the brain, which supplies oxygen-rich blood to the tissues. Factors contributing to the formation of intracranial aneurysm are hypertension, smoking, injury or trauma to the blood vessels, complication from few types of blood infections, and genetic predisposition. The treatment of intracranial aneurysm includes medical therapy, surgical clipping or therapy and endovascular therapy or coiling without or with adjunctive devices.
Intracranial Aneurysm Treatment Market contains market size and forecasts of Intracranial Aneurysm Treatment in Global, including the following market information:
- Global Intracranial Aneurysm Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Intracranial Aneurysm Treatment market was valued at 1116.1 million in 2021 and is projected to reach US$ 1718.9 million by 2028, at a CAGR of 6.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Surgical Clipping Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Intracranial Aneurysm Treatment include Medtronic, Microport Scientific Corporation, B. Braun, Stryker, Johnson and Johnson, Microvention Inc., Codman Neuro (Integra Lifesciences), Raumedic AG and Integra Life Sciences Corporation. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Intracranial Aneurysm Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intracranial Aneurysm Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Intracranial Aneurysm Treatment Market Segment Percentages, by Type, 2021 (%)
- Surgical Clipping
- Endovascular Coiling
- Flow Diverters
- Others
Global Intracranial Aneurysm Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Intracranial Aneurysm Treatment Market Segment Percentages, by Application, 2021 (%)
Global Intracranial Aneurysm Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Intracranial Aneurysm Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Intracranial Aneurysm Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Intracranial Aneurysm Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Medtronic
- Microport Scientific Corporation
- B. Braun
- Stryker
- Johnson and Johnson
- Microvention Inc.
- Codman Neuro (Integra Lifesciences)
- Raumedic AG
- Integra Life Sciences Corporation
Industry Market Size
